Cell BiologyCell Reports MedicinePeer-reviewed
A High Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury during the COVID-19 pandemic
M. Malimova, E.-H. Sidhom, A. Satyam…·A. Greka
The paper identifies Fostamatinib as a potential repurposing drug for acute lung injury by reducing MUC1 protein levels in preclinical models.
DOI 10.1016/j.xcrm.2020.100137